The Juvenile Diabetes Research Foundation (JDRF) said that it will begin a diabetes research collaboration with Pfizer, …
Research
Amylin and Takeda Advance Development of New Obesity Treatment
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced that following positive phase 2 study r…
Study Shows Vinegar Reduces Blood Glucose Levels
A new study shows vinegar reduces post-meal hyperglycemia in type 1 diabetics. While previous studies have shown that v…
Mechanism Leading to Diabetic Blindness Identified
Diabetic retinopathy is a common side effect of diabetes and the leading cause of blindness in young adults in the Unite…
Swedish Company, Diamyd Medical AB, Plans to Have Diabetes Vaccine by 2011
Diamyd Medical AB, a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoim…
Osiris Completes Enrollment in Stem Cell Trial for Type 1 Diabetes
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes R…
FDA Clears Clibra’s Insulin Patch
Calibra Medical Inc., formerly known as Seattle Medical Technologies Inc., announced today that the U.S. Food and Drug A…
JDRF Announces Diabetes Research Program with Johnson & Johnson
The Juvenile Diabetes Research Foundation announced today in a press release that it will begin working with The Johnson…
FDA Approves Diamyd Vaccine Study In Children As Young As 3
Diamyd Medical, a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoimmun…
Diabetes UK to Fund New Diabetes Research
Diabetes UK announced that it would be dedicating almost £750,000 ($1,200,000) to four new research projects looking to …
